Ozem­pic short­ages have Eu­ro­pean coun­tries ex­plor­ing bans on use of pop­u­lar drug for weight loss

Bel­gium banned the use of No­vo Nordisk’s di­a­betes drug Ozem­pic for weight loss this week, and Ger­many is con­sid­er­ing a sim­i­lar ac­tion amid short­ages of …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.